Table 1 Relationship between Linc00959 expression and clinicopathological features in 290 breast cancer patients for IHC detection
From: High expression of Linc00959 predicts poor prognosis in breast cancer
Characteristics | Linc00959 | Number of patients (%) | p value | |
|---|---|---|---|---|
Low n (%) | High n (%) | |||
Total | 67 (23.1) | 223 (76.9) | 290 | |
Age | 0.448 | |||
< 50 | 59 (20.3) | 188 (2.8) | 247 (23.1) | |
≥ 50 | 8 (64.8) | 35 (12.1) | 43 (76.9) | |
Tumor size (cm) | 0.871 | |||
≤ 2 cm | 26 (9) | 78 (26.9) | 104 (35.9) | |
> 2, 5 ≤ cm | 39 (13.4) | 137 (47.2) | 176 (60.7) | |
> 5 cm | 2 (0.6) | 8 (2.8) | 10 (3.4) | |
Node status | 0.100 | |||
Negative | 34 (11.7) | 108 (37.2) | 142 (49) | |
Positive | 33 (11.4) | 115 (39.7) | 148 (51) | |
ER status | 0.005 | |||
Negative | 20 (6.9) | 111 (38.3) | 131 (45.2) | |
Positive | 47 (16.2) | 112 (38.6) | 159 (54.8) | |
PR status | 0.036 | |||
Negative | 23 (7.9) | 110 (37.9) | 133 (45.9) | |
Positive | 44 (15.2) | 113 (39) | 157 (54.1) | |
HER-2 status | 0.009 | |||
Negative | 39 (13.4) | 145 (50) | 184 (63.4) | |
Positive | 24 (8.3) | 77 (26.6) | 101 (36.6) | |
Ki67 | 0.025 | |||
Negative | 39 (13.4) | 93 (32.1) | 132 (45.5) | |
Positive | 28 (9.7) | 130 (44.8) | 158 (54.5) | |
Vessel invasion | 0.264 | |||
Negative | 41 (14.1) | 118 (40.7) | 159 (54.8) | |
Positive | 26 (9) | 105 (36.2) | 131 (45.2) | |
Subtype | 0.923 | |||
I | 31 (10.7) | 54 (18.6) | 85 (29.3) | |
II | 17 (5.9) | 58 (20) | 75 (25.9) | |
III | 8 (2.8) | 58 (18.4) | 66 (21.2) | |
IV | 11 (3.8) | 53 (18.3) | 64 (22.1) | |
TNM stage | 0.055 | |||
I | 17 (5.9) | 47 (16.2) | 64 (22.1) | |
II | 33 (11.4) | 114 (39.3) | 147 (50.7) | |
III | 17 (5.9) | 61 (21) | 78 (26.9) | |